Safety and effectiveness of bivalirudin in routine care of patients undergoing percutaneous coronary intervention.

PubWeight™: 0.89‹?›

🔗 View Article (PMC 2831765)

Published in Eur Heart J on November 25, 2009

Authors

Jeremy A Rassen1, Murray A Mittleman, Robert J Glynn, M Alan Brookhart, Sebastian Schneeweiss

Author Affiliations

1: Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02120, USA. jrassen@post.harvard.edu

Articles cited by this

'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol (2003) 16.71

Does more intensive treatment of acute myocardial infarction in the elderly reduce mortality? Analysis using instrumental variables. JAMA (1994) 11.32

Analysis of observational studies in the presence of treatment selection bias: effects of invasive cardiac management on AMI survival using propensity score and instrumental variable methods. JAMA (2007) 10.62

A review of uses of health care utilization databases for epidemiologic research on therapeutics. J Clin Epidemiol (2005) 8.77

Instruments for causal inference: an epidemiologist's dream? Epidemiology (2006) 8.50

Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med (2005) 8.44

Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med (2005) 6.65

Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med (2008) 5.86

Econometrics in outcomes research: the use of instrumental variables. Annu Rev Public Health (1998) 5.55

Bivalirudin for patients with acute coronary syndromes. N Engl J Med (2006) 5.49

Hospital characteristics associated with adverse events and substandard care. JAMA (1991) 4.77

Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial. JAMA (2003) 4.74

Evaluating short-term drug effects using a physician-specific prescribing preference as an instrumental variable. Epidemiology (2006) 3.54

Aprotinin during coronary-artery bypass grafting and risk of death. N Engl J Med (2008) 2.59

Adjusting effect estimates for unmeasured confounding with validation data using propensity score calibration. Am J Epidemiol (2005) 2.55

Teaching hospitals and quality of care: a review of the literature. Milbank Q (2002) 2.39

Adjusting for unmeasured confounders in pharmacoepidemiologic claims data using external information: the example of COX2 inhibitors and myocardial infarction. Epidemiology (2005) 2.38

Preference-based instrumental variable methods for the estimation of treatment effects: assessing validity and interpreting results. Int J Biostat (2007) 2.24

Lipid-lowering therapy and in-hospital mortality following major noncardiac surgery. JAMA (2004) 2.20

ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). J Am Coll Cardiol (2006) 2.16

An application of propensity score matching using claims data. Pharmacoepidemiol Drug Saf (2005) 2.15

Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trial. JAMA (2007) 1.84

A Medicare database review found that physician preferences increasingly outweighed patient characteristics as determinants of first-time prescriptions for COX-2 inhibitors. J Clin Epidemiol (2005) 1.83

A modified least-squares regression approach to the estimation of risk difference. Am J Epidemiol (2007) 1.78

Instrumental variables I: instrumental variables exploit natural variation in nonexperimental data to estimate causal relationships. J Clin Epidemiol (2009) 1.73

Quality of care in teaching hospitals: a literature review. Acad Med (2005) 1.64

Instrumental variable analysis for estimation of treatment effects with dichotomous outcomes. Am J Epidemiol (2008) 1.59

Instrumental variables II: instrumental variable application-in 25 variations, the physician prescribing preference generally was strong and reduced covariate imbalance. J Clin Epidemiol (2009) 1.56

Determinants of selective cyclooxygenase-2 inhibitor prescribing: are patient or physician characteristics more important? Am J Med (2003) 1.53

Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial. JAMA (2004) 1.42

Bivalirudin versus unfractionated heparin during percutaneous coronary intervention. N Engl J Med (2008) 1.37

Correlates of procedural complications and a simple integer risk score for percutaneous coronary intervention. J Am Coll Cardiol (2002) 1.29

Antithrombotic therapy during percutaneous coronary intervention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest (2004) 1.07

Should bivalirudin replace heparin during percutaneous coronary interventions? JAMA (2003) 0.83

Current update on glycoprotein IIb-IIIa and direct thrombin inhibition in percutaneous coronary intervention for non-ST elevation acute coronary syndromes: balancing bleeding risk and antiplatelet efficacy. J Interv Cardiol (2008) 0.76

Articles by these authors

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med (2008) 43.36

Particulate matter air pollution and cardiovascular disease: An update to the scientific statement from the American Heart Association. Circulation (2010) 19.30

Variable selection for propensity score models. Am J Epidemiol (2006) 10.68

Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial. Lancet (2009) 10.52

Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. N Engl J Med (2003) 8.65

Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med (2005) 8.44

Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA (2008) 8.32

High-dimensional propensity score adjustment in studies of treatment effects using health care claims data. Epidemiology (2009) 7.40

A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods. J Clin Epidemiol (2005) 7.31

Long-term persistence in use of statin therapy in elderly patients. JAMA (2002) 7.19

Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records. Am Heart J (2004) 6.57

Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect. Am J Epidemiol (2005) 6.20

Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men. N Engl J Med (2003) 5.95

A randomized study of how physicians interpret research funding disclosures. N Engl J Med (2012) 5.47

Multivitamins in the prevention of cancer in men: the Physicians' Health Study II randomized controlled trial. JAMA (2012) 5.25

Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians' Health Study II randomized controlled trial. JAMA (2008) 5.13

Risk of death and cardiovascular events in initially healthy women with new-onset atrial fibrillation. JAMA (2011) 4.73

Indications for propensity scores and review of their use in pharmacoepidemiology. Basic Clin Pharmacol Toxicol (2006) 4.70

Full coverage for preventive medications after myocardial infarction. N Engl J Med (2011) 4.51

The comparative safety of analgesics in older adults with arthritis. Arch Intern Med (2010) 4.47

Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial. Lancet (2012) 4.46

Sexual function in men older than 50 years of age: results from the health professionals follow-up study. Ann Intern Med (2003) 4.40

Multivitamins in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA (2012) 4.40

Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trials. Circulation (2010) 4.37

HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial. Lancet (2010) 4.07

Outcomes of reference pricing for angiotensin-converting-enzyme inhibitors. N Engl J Med (2002) 4.07

Depression and risk of sudden cardiac death and coronary heart disease in women: results from the Nurses' Health Study. J Am Coll Cardiol (2009) 3.99

A combined comorbidity score predicted mortality in elderly patients better than existing scores. J Clin Epidemiol (2011) 3.98

Anticonvulsant medications and the risk of suicide, attempted suicide, or violent death. JAMA (2010) 3.85

The epidemiology of prescriptions abandoned at the pharmacy. Ann Intern Med (2010) 3.78

Suicide and cardiovascular death after a cancer diagnosis. N Engl J Med (2012) 3.56

Evaluating short-term drug effects using a physician-specific prescribing preference as an instrumental variable. Epidemiology (2006) 3.54

Analytic strategies to adjust confounding using exposure propensity scores and disease risk scores: nonsteroidal antiinflammatory drugs and short-term mortality in the elderly. Am J Epidemiol (2005) 3.33

The implications of therapeutic complexity on adherence to cardiovascular medications. Arch Intern Med (2011) 3.27

Blood pressure and risk of developing type 2 diabetes mellitus: the Women's Health Study. Eur Heart J (2007) 3.21

Cardiovascular outcomes and mortality in patients using clopidogrel with proton pump inhibitors after percutaneous coronary intervention or acute coronary syndrome. Circulation (2009) 3.09

Tumor necrosis factor alpha antagonist use and cancer in patients with rheumatoid arthritis. Arthritis Rheum (2006) 3.04

High-density lipoprotein cholesterol, size, particle number, and residual vascular risk after potent statin therapy. Circulation (2013) 3.03

Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis. JAMA (2011) 3.02

Confounding control in healthcare database research: challenges and potential approaches. Med Care (2010) 3.01

Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults. Circulation (2004) 2.98

Efficacy of rosuvastatin among men and women with moderate chronic kidney disease and elevated high-sensitivity C-reactive protein: a secondary analysis from the JUPITER (Justification for the Use of Statins in Prevention-an Intervention Trial Evaluating Rosuvastatin) trial. J Am Coll Cardiol (2010) 2.93

Ambient air pollution and the risk of acute ischemic stroke. Arch Intern Med (2012) 2.92

Insights into the mechanisms and mediators of the effects of air pollution exposure on blood pressure and vascular function in healthy humans. Hypertension (2009) 2.88

Noncompliance with antihypertensive medications: the impact of depressive symptoms and psychosocial factors. J Gen Intern Med (2002) 2.85

Nonsteroidal anti-inflammatory drug use and acute myocardial infarction. Arch Intern Med (2002) 2.82

Selective prescribing led to overestimation of the benefits of lipid-lowering drugs. J Clin Epidemiol (2006) 2.81

Driving and implantable cardioverter-defibrillator shocks for ventricular arrhythmias: results from the TOVA study. J Am Coll Cardiol (2007) 2.79

Treatment effects in the presence of unmeasured confounding: dealing with observations in the tails of the propensity score distribution--a simulation study. Am J Epidemiol (2010) 2.74

Inhibition of clinical benefits of aspirin on first myocardial infarction by nonsteroidal antiinflammatory drugs. Circulation (2003) 2.73

The comparative safety of opioids for nonmalignant pain in older adults. Arch Intern Med (2010) 2.71

Comparative mortality risk of anemia management practices in incident hemodialysis patients. JAMA (2010) 2.71

The U.S. Food and Drug Administration's Mini-Sentinel program: status and direction. Pharmacoepidemiol Drug Saf (2012) 2.70

Air pollution and hospital admissions for ischemic and hemorrhagic stroke among medicare beneficiaries. Stroke (2005) 2.66

Identification of individuals with CKD from Medicare claims data: a validation study. Am J Kidney Dis (2005) 2.65

Improved comorbidity adjustment for predicting mortality in Medicare populations. Health Serv Res (2003) 2.65

Modeling the association between particle constituents of air pollution and health outcomes. Am J Epidemiol (2012) 2.64

Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis. J Am Coll Cardiol (2008) 2.58

Excess weight and the risk of incident coronary heart disease among men and women. Obesity (Silver Spring) (2009) 2.56

Performance of propensity score calibration--a simulation study. Am J Epidemiol (2007) 2.56

Adjusting effect estimates for unmeasured confounding with validation data using propensity score calibration. Am J Epidemiol (2005) 2.55

Repeated hospitalizations predict mortality in the community population with heart failure. Am Heart J (2007) 2.55

Particulate air pollution and hospital admissions for congestive heart failure in seven United States cities. Am J Cardiol (2006) 2.54

Medicaid prior-authorization programs and the use of cyclooxygenase-2 inhibitors. N Engl J Med (2004) 2.52

Incorporation of clustering effects for the Wilcoxon rank sum test: a large-sample approach. Biometrics (2003) 2.49

Exercise and acute cardiovascular events placing the risks into perspective: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism and the Council on Clinical Cardiology. Circulation (2007) 2.49

Intervening on risk factors for coronary heart disease: an application of the parametric g-formula. Int J Epidemiol (2009) 2.48

Statin adherence and risk of accidents: a cautionary tale. Circulation (2009) 2.47

Risk of acute myocardial infarction after the death of a significant person in one's life: the Determinants of Myocardial Infarction Onset Study. Circulation (2012) 2.44

Evaluating uses of data mining techniques in propensity score estimation: a simulation study. Pharmacoepidemiol Drug Saf (2008) 2.42

Long-term multivitamin supplementation and cognitive function in men: a randomized trial. Ann Intern Med (2013) 2.39

Adjusting for unmeasured confounders in pharmacoepidemiologic claims data using external information: the example of COX2 inhibitors and myocardial infarction. Epidemiology (2005) 2.38

The impact of marijuana use on glucose, insulin, and insulin resistance among US adults. Am J Med (2013) 2.36

Association of air pollution with increased incidence of ventricular tachyarrhythmias recorded by implanted cardioverter defibrillators. Environ Health Perspect (2005) 2.36

Increasing levels of restriction in pharmacoepidemiologic database studies of elderly and comparison with randomized trial results. Med Care (2007) 2.31

Influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in women. Circulation (2009) 2.26

A prospective study of risk factors for erectile dysfunction. J Urol (2006) 2.25

Preference-based instrumental variable methods for the estimation of treatment effects: assessing validity and interpreting results. Int J Biostat (2007) 2.24

Chimney stove intervention to reduce long-term wood smoke exposure lowers blood pressure among Guatemalan women. Environ Health Perspect (2007) 2.23

A randomized trial of beta carotene supplementation and cognitive function in men: the Physicians' Health Study II. Arch Intern Med (2007) 2.20

Treatment of older adult patients diagnosed with rheumatoid arthritis: improved but not optimal. Arthritis Rheum (2007) 2.18

Use of topiramate in pregnancy and risk of oral clefts. Am J Obstet Gynecol (2012) 2.14

Patterns of medication initiation in newly diagnosed diabetes mellitus: quality and cost implications. Am J Med (2012) 2.13

Assessing health state utilities in elderly patients at cardiovascular risk. Med Decis Making (2006) 2.12